Twist Bioscience Faces Negative Report from The Bear Cave and Hunterbrook
Twist Bioscience Corporation shares declined following the release of a critical report by The Bear Cave and Hunterbrook.
Stocks · News reference
Notice of Proposed Derivative Settlement: Twist Bioscience Corporation
Twist Bioscience Corporation has issued a summary notice regarding a proposed settlement in a derivative action pending in the U.S. District Court for the District of Delaware.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Twist Bioscience Stock Sinks as Bear Cave Raises Valuation Concerns
Twist Bioscience Corp (NASDAQ:TWST) shares are plunging Thursday. The Bear Cave, which Hunterbrook Media owns, said that the life science tools company's stock price may have run ahead of its fundamentals. Here's what you should know.
Watching Twist Bioscience; The Bear Cave Newsletter Issues Report On Co Titled "Problems at Twist Bioscience (TWST)"
Ark Invest Sells $7.3 Million in Twist Bioscience Shares
Ark Invest reduced its position in Twist Bioscience, selling $7.3 million worth of shares on November 2, 2026.
Twist Bioscience Launches Express Screening Antibodies
Twist Bioscience has introduced a new express screening antibody service to expand its production and characterization portfolio.
Twist Bioscience Launches Twist MRD Express for Cancer Research
Twist Bioscience has introduced Twist MRD Express, a new line of custom panels designed for rapid, high-throughput molecular residual disease (MRD) research in oncology.